198 related articles for article (PubMed ID: 22151386)
21. Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase.
Auclair Y; Rouget R; Belisle JM; Costantino S; Drobetsky EA
DNA Repair (Amst); 2010 Jul; 9(7):754-64. PubMed ID: 20457011
[TBL] [Abstract][Full Text] [Related]
22. Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure.
Terhorst D; Drecoll U; Stockfleth E; Ulrich C
Br J Dermatol; 2009 Nov; 161 Suppl 3():85-9. PubMed ID: 19775362
[TBL] [Abstract][Full Text] [Related]
23. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine.
de Graaf YG; Rebel H; Elghalbzouri A; Cramers P; Nellen RG; Willemze R; Bouwes Bavinck JN; de Gruijl FR
Exp Dermatol; 2008 Apr; 17(4):349-55. PubMed ID: 17979968
[TBL] [Abstract][Full Text] [Related]
24. The historical link between solid-organ transplantation, immunosuppression, and skin cancer.
Randle HW
Dermatol Surg; 2004 Apr; 30(4 Pt 2):595-7. PubMed ID: 15061841
[TBL] [Abstract][Full Text] [Related]
25. [Monitoring and secondary effects of immunosuppressants in the transplant].
Sádaba B
An Sist Sanit Navar; 2006; 29 Suppl 2():207-18. PubMed ID: 16998527
[TBL] [Abstract][Full Text] [Related]
26. [Skin cancer in renal transplant recipients].
Mangino M; Schena FP
G Ital Nefrol; 2010; 27 Suppl 50():S75-80. PubMed ID: 20922700
[TBL] [Abstract][Full Text] [Related]
27. Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas.
Rival-Tringali AL; Euvrard S; Decullier E; Claudy A; Faure M; Kanitakis J
Anticancer Res; 2009 Jun; 29(6):1927-32. PubMed ID: 19528449
[TBL] [Abstract][Full Text] [Related]
28. Multiple involvement of nucleotide excision repair enzymes: clinical manifestations of molecular intricacies.
Jaspers NG
Cytokines Mol Ther; 1996 Jun; 2(2):115-9. PubMed ID: 9384696
[TBL] [Abstract][Full Text] [Related]
29. Evidence for immunosuppression in lung transplantation.
Hopkins PM; McNeil K
Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
[TBL] [Abstract][Full Text] [Related]
30. Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies.
Thaçi D; Salgo R
Clin Dermatol; 2010; 28(1):52-6. PubMed ID: 20082951
[TBL] [Abstract][Full Text] [Related]
31. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients.
Ulrich C; Schmook T; Sachse MM; Sterry W; Stockfleth E
Dermatol Surg; 2004 Apr; 30(4 Pt 2):622-7. PubMed ID: 15061846
[TBL] [Abstract][Full Text] [Related]
32. [Repair of DNA damage using nucleotide excision repair (NER)--relationship with cancer risk].
Butkiewicz D; Rusin M; Pawlas M; Czarny M; Chorazy M
Postepy Hig Med Dosw; 2002; 56(4):485-98. PubMed ID: 12418414
[TBL] [Abstract][Full Text] [Related]
33. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
Kovach BT; Sams HH; Stasko T
Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
[TBL] [Abstract][Full Text] [Related]
34. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
35. Minimizing the risk of posttransplant malignancy.
Campistol JM
Transplant Proc; 2008 Dec; 40(10 Suppl):S40-3. PubMed ID: 19100906
[TBL] [Abstract][Full Text] [Related]
36. Skin cancer in organ transplant recipients: more than the immune system.
Wheless L; Jacks S; Mooneyham Potter KA; Leach BC; Cook J
J Am Acad Dermatol; 2014 Aug; 71(2):359-65. PubMed ID: 24725477
[TBL] [Abstract][Full Text] [Related]
37. [Low-toxicity immunosuppressive therapy in renal transplant].
Scolari F; La Manna G; Comai G; Cappuccilli ML; Todeschini P; Ciavatti A; Persici E; Feliciangeli G; Stefoni S
G Ital Nefrol; 2007; 24 Suppl 38():44-8. PubMed ID: 17922447
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive agents in organ transplantation: past, present, and future.
Hong JC; Kahan BD
Semin Nephrol; 2000 Mar; 20(2):108-25. PubMed ID: 10746855
[TBL] [Abstract][Full Text] [Related]
39. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
40. Suppression of UV carcinogenesis by difluoromethylornithine in nucleotide excision repair-deficient Xpa knockout mice.
Rebel H; van Steeg H; Beems RB; Schouten R; de Gruijl FR; Terleth C
Cancer Res; 2002 Mar; 62(5):1338-42. PubMed ID: 11888902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
